课题基金 / 基金详情

HIV and Cocaine Drive Bone-Marrow Blood (BMB) Barrier Dysfunction and Altered Hematopoietic Stem Cell (HSC) Differentiation Leading to Cardiovascular Disease

HIV and Cocaine Drive Bone-Marrow Blood (BMB) Barrier Dysfunction and Altered Hematopoietic Stem Cell (HSC) Differentiation Leading to Cardiovascular Disease
HIV 和可卡因导致骨髓血液 (BMB) 屏障功能障碍和造血干细胞 (HSC) 分化改变,导致心血管疾病
批准号:
10469745
负责人:
Allison Michelle Andrews
金额:
$237.75万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-04-01 至 2026-03-31

项目摘要

项目成果

Allison Michelle Andrews的其他基金

相似基金

相关文献

中文摘要
翻译
艾滋病毒携带者(PLWH),即使接受了抗逆转录病毒治疗(ART),也有加速和增强的 非艾滋病相关疾病的发病,如心血管疾病(CVD)的过早发展。在……里面 事实上,心血管疾病已成为美国PLWH中非艾滋病相关死亡的第二大常见原因。 在这里,我们的目标是破译HIV相关心血管疾病的潜在机制。具体地说,我们的重点是 骨髓-血(BMB)屏障和干细胞巢,作为一个脆弱的微环境调节 脑血管病的免疫状态。骨髓(BM)是造血干细胞(HSCs)的重要储存库, 产生免疫细胞,包括循环单核细胞(炎症性和非炎症性)。近期 研究强调了血管通透性(或缺乏通透性)在控制HSC中的重要性。 差异化。此外,骨髓壁龛的血管构筑区域负责维持长期的 造血干细胞表现出与血脑相似的限制性通透性(受周细胞调节)。 障碍。虽然艾滋病毒感染在抗逆转录病毒治疗时代对骨髓的影响尚不清楚,但它可能反映了所观察到的情况。 在大脑里。值得注意的是,众所周知,艾滋病毒感染和大脑中的炎症导致减少 周细胞覆盖和血管通透性增加。流行病学研究表明,并存 物质使用障碍在PLWH中很常见。此外,滥用药物的情况在 加剧了艾滋病毒的病理。例如,长期使用可卡因独立地增加了心血管疾病的风险,并进一步 加强其在PLWH的发展,突出艾滋病毒感染和可卡因使用之间的协同联系。我们 建议增加因艾滋病毒感染而导致的骨髓血管破裂和减少周细胞覆盖率 可卡因可以改变HSC分化的平衡,并驱动潜在的慢性免疫激活 这会促进心血管疾病的进展。因此,我们的假设是HIV和可卡因诱导BMB屏障 使HSC偏向分化和产生炎性单核细胞的功能障碍 促进早期心脑血管疾病。对功能失调的骨髓微环境的研究从未被作为一个因素进行检查 在艾滋病毒感染/吸毒期间的心血管疾病。我们的方法在概念和技术上都是高度创新的, 将是第一个研究BMB屏障变化的人。这一假设将通过组织清除来检验, 用MicroCT和先进成像技术绘制人源化HIV感染者的三维血管构筑图 老鼠。最后,我们建议建立一种新的人骨髓血管三维组织工程模型,用于 HIV致病机制的研究。简而言之,慢性免疫激活被认为是导致早熟的主要因素 艾滋病毒+/慢性可卡因使用者的心血管疾病;然而,根本原因尚不清楚。因此,识别 免疫激活机制可能导致对HIV+患者/吸毒者的靶向治疗和 减缓或防止斑块发展的管理策略。这些研究符合 Avenir DP2计划鼓励早期调查人员以创新的方法追求大胆的想法。
英文摘要
People living with HIV (PLWH), even with anti-retroviral therapy (ART), have an accelerated and augmented onset of non-AIDS related diseases such as the premature development of cardiovascular disease (CVD). In fact, CVD has become the second most common cause of non-AIDS related mortality in PLWH in the US. Herein, we aim to decipher the underlying mechanism for HIV-associated CVD. Specifically, our focus is on the bone marrow-blood (BMB) barrier and stem cell niche, as a vulnerable microenvironment that regulates the immune status in CVD. The bone marrow (BM) is an important reservoir for hematopoietic stem cells (HSCs), which give rise to immune cells including circulatory monocytes (inflammatory vs non-inflammatory). Recent studies have highlighted the importance of vasculature permeability (or lack thereof) in controlling HSC differentiation. Additionally, areas of the vasculature in the BM niches responsible for maintaining the long-term HSCs exhibit restrictive permeability properties (regulated by pericytes) similar to that of the blood-brain barrier. While the effect of HIV infection in the BM in the era of ART is unknown, it may mirror what is observed in the brain. Of note, it is well established that HIV infection and inflammation in the brain leads to reduced pericyte coverage and increased vascular permeability. Epidemiological studies indicate that comorbid substance use disorder is common in PLWH. Furthermore, drugs of abuse are well documented in exacerbating HIV pathology. For example, chronic cocaine use independently increases CVD risk and further augments its development in PLWH, highlighting a synergistic link between HIV infection and cocaine use. We propose that increased BM vascular disruption and reduced pericyte coverage resulting from HIV infection and cocaine could alter the balance of HSC differentiation and drive the underlying chronic immune activation which advances CVD progression. Thus, our hypothesis is that HIV and cocaine induce BMB barrier dysfunction which skews HSCs towards differentiation and production of inflammatory monocytes that promote early CVD. The study of dysfunctional BM microenvironments has never been examined as a factor in CVD during HIV infection/drug use. Our approach is highly conceptually and technically innovative and would be the first to study changes in the BMB barrier. This hypothesis will be examined using tissue clearing, microCT and advanced imaging techniques to map the 3D vascular architecture in humanized HIV-infected mice. Finally, we propose to develop a new human 3D tissue engineered model of the BM vasculature for the study of HIV pathogenesis. In brief, chronic immune activation is considered the leading factor driving early CVD in HIV+/chronic cocaine users; however, the underlying cause remains unknown. Therefore, identifying the mechanism of immune activation could lead to targeted treatment of HIV+ patients/drug users and management strategies to slow or prevent plaque development. These studies fit within the framework of the Avenir DP2 program to encourage early-stage investigators to pursue bold ideas with innovative approaches.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Innovative In-Situ Imaging Techniques for the Visualization of CNS associated HIV reservoirs in the Context of Substance Abuse
  • 批准号:
    10682957
  • 项目类别:
  • 资助金额:
    $58.69万
  • 财政年份:
    2023
  • 负责人:
    Allison Michelle Andrews
  • 依托单位:
Role of Patrolling Monocytes in Cerebral Vascular Repair during HIV/Substance Abuse
  • 批准号:
    10331315
  • 项目类别:
  • 资助金额:
    $14.99万
  • 财政年份:
    2019
  • 负责人:
    Allison Michelle Andrews
  • 依托单位:
Role of Patrolling Monocytes in Cerebral Vascular Repair during HIV/Substance Abuse
  • 批准号:
    10080722
  • 项目类别:
  • 资助金额:
    $14.99万
  • 财政年份:
    2019
  • 负责人:
    Allison Michelle Andrews
  • 依托单位:
Role of Patrolling Monocytes in Cerebral Vascular Repair during HIV/Substance Abuse
  • 批准号:
    10557168
  • 项目类别:
  • 资助金额:
    $14.99万
  • 财政年份:
    2019
  • 负责人:
    Allison Michelle Andrews
  • 依托单位:
海外基金